Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

99mTc-MAEC Complexes: New Renal Radiopharmaceuticals Combining Characteristics of 99mTc-MAG3 and 99mTc-EC

Andrew T. Taylor, Malgorzata Lipowska, Lory Hansen, Eugene Malveaux and Luigi G. Marzilli
Journal of Nuclear Medicine May 2004, 45 (5) 885-891;
Andrew T. Taylor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malgorzata Lipowska
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lory Hansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugene Malveaux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi G. Marzilli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

FIGURE 3.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Data were acquired in 1 volunteer after simultaneous injection of 69.93 MBq (1.89 mCi) syn-99mTc-d-MAEC and 11.47 MBq (0.31 mCi) 131I-OIH; postvoid images were acquired ∼30 min after injection. The 2-min syn-99mTc-d-MAEC images (A) and renogram curves (B) can be compared with simultaneously acquired 131I-OIH images (C) and renogram curves (D). (A) Sequential 2-min images after injection of 69.93 MBq (1.89 mCi) syn-99mTc-d-MAEC; differential (relative) uptake is 51.3% in left kidney and 48.7% in right kidney. Final image is postvoid image obtained ∼30 min after injection. (B) Renogram curves and curve parameters based on whole kidney ROIs assigned over kidneys in A. Whole kidney and background ROIs are superimposed over the 2- to 3- and 19- to 20-min images at top. TTP refers to time-to-peak height of renogram curve and values are expressed in minutes; 20/max expression refers to ratio of counts at 20 min divided by maximum counts; 20/2–3 expression refers to ratio of counts at 19–20 min divided by counts at 2–3 min; TT1/2P refers to time (minutes) for counts in renogram curve to fall to half of peak value. RT = right; LT = left. (C) Sequential 2-min images after injection of 11.47 MBq (0.31 mCi) 131I-OIH. 131I-OIH images were acquired simultaneously as syn-99mTc-d-MAEC images in A. Differential (relative) uptake is 54.3% in left kidney and 45.7% in right kidney. Final image is postvoid image obtained ∼30 min after injection. (D) Renogram curves and curve parameters based on whole kidney ROIs assigned over kidneys in A and applied to 131I-OIH image data (C). Whole kidney and background ROIs are superimposed over 2- to 3- and 19- to 20-min images at top. TTP, 20/max expression, 20/2–3 expression, and TT1/2P are as described in B.

  View article

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FIGURE 3.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
99mTc-MAEC Complexes: New Renal Radiopharmaceuticals Combining Characteristics of 99mTc-MAG3 and 99mTc-EC
Andrew T. Taylor, Malgorzata Lipowska, Lory Hansen, Eugene Malveaux, Luigi G. Marzilli
Journal of Nuclear Medicine May 2004, 45 (5) 885-891;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
99mTc-MAEC Complexes: New Renal Radiopharmaceuticals Combining Characteristics of 99mTc-MAG3 and 99mTc-EC
Andrew T. Taylor, Malgorzata Lipowska, Lory Hansen, Eugene Malveaux, Luigi G. Marzilli
Journal of Nuclear Medicine May 2004, 45 (5) 885-891;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Preclinical Evaluation of 99mTc(CO)3-Aspartic-N-Monoacetic Acid, a Renal Radiotracer with Pharmacokinetic Properties Comparable to 131I-o-Iodohippurate
  • Synthesis and In Vivo Evaluation of p-18F-Fluorohippurate as a New Radiopharmaceutical for Assessment of Renal Function by PET
  • 99mTc(CO)3(NTA): A 99mTc Renal Tracer with Pharmacokinetic Properties Comparable to Those of 131I-OIH in Healthy Volunteers
  • 99mTc(CO)3-Nitrilotriacetic Acid: A New Renal Radiopharmaceutical Showing Pharmacokinetic Properties in Rats Comparable to Those of 131I-OIH
  • First Evaluation of a 99mTc-Tricarbonyl Complex, 99mTc(CO)3(LAN), as a New Renal Radiopharmaceutical in Humans
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire